T1	Participants 444 680	patients with SLE according to the ACR criteria, with incident (no more than 15 days) onset of severe NP manifestations such as seizures, optic neuritis, peripheral or cranial neuropathy, coma, brainstem disease, or transverse myelitis.
T2	Participants 119 147	systemic lupus erythematosus
T3	Participants 1124 1135	32 patients
